Tevogen Bio Holdings Inc (TVGN)

[glenn1919]

TVGN............................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[Stock Guy777]

Well, there you go you heard it from AI itself. It's gotta be true.!😊

[Invest-in-America]

TVGN: This firm PR's about stuff that has patently-NOTHING to do with their company!!!
https://finance.yahoo.com/news/tevogen-bio-ceo-congratulates-lynne-192400945.html

[Invest-in-America]

TVGN: Holy SHEEEEET!!! Look at THIS news!!! (Heck, I'm startin' to LIKE this pumpin' cheescake routine!!!)
https://finance.yahoo.com/news/tevogen-bio-ceo-congratulates-lynne-192400945.html
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

[Invest-in-America]

TVGN: See below what Bing's "Copilot" has to say about TVGN:

MY QUESTION FOR COPILOT: "Does Wall Street believe that TVGN's repeated PR's of late --- about BROADENING and EXPANDING their purported AI COLLABORATION with Microsoft Corp. --- are merely attempts to superficially-INFLATE the price of TVGN's STOCK?"

COPILOT'S REPLY: "It's understandable to be skeptical about such announcements. While Tevogen Bio (TVGN) has indeed expanded its AI collaboration with Microsoft, aiming to advance its PredicTcell technology and other immunotherapy treatments, some investors and analysts might view these repeated PRs as attempts to boost stock prices. However, it's important to note that the collaboration does involve significant technological advancements and potential for future growth. The stock price has seen some fluctuations, but it's also received a BUY rating from analysts, with a price target suggesting substantial upside potential. Ultimately, whether these PRs are seen as genuine efforts to advance technology or as attempts to inflate stock prices can vary among investors. It's always a good idea to do thorough research and consider multiple perspectives before making any investment decisions."

[Invest-in-America]

TVGN: In their 1-24-25 baloney PR, they deployed the word "DEEPEN"; and now, they deploy the word "EXPAND" their relationship with Microsoft!!! (PURE FLUFF BULLSHIT!!!)

[Invest-in-America]

TVGN: Identical news they had on 1-24-25. (And their FLOAT is too big.)

[glenn1919]

tvgn.............................https://stockcharts.com/h-sc/ui?s=tvgn&p=W&b=5&g=0&id=p86431144783

[Invest-in-America]

TVGN: Is glorious Microsoft really proactively 'collaborating' with tiny TVGN; or, is TVGN merely EXPLOITING Microsoft's already-existing AI services & products??? (Be very careful when a little-known company suddenly publishes so-called 'NEWS' with terms like 'partnering with', or 'teaming with', or 'collaborating with', or 'broadens relationship with', a well-known GOLIATH company like Microsoft --- when, in truth, the little firm is a typical punk DAVID-WITH-A-SLINGSHOT seeking Holy-Bible-like fame & fortune!!!)
https://finance.yahoo.com/news/tevogen-bio-broadens-relationship-microsoft-223400494.html
///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////

[jjtcwine]

$TVGN $1.70 $MSFT NEWS Tevogen Bio announces AI collaboration with Microsoft PR release !!!

[glenn1919]

TVGN..............................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[glenn1919]

TVGN....................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[glenn1919]

TVGN.................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[glenn1919]

TVGN....................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[glenn1919]

TVGN...........................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[Joe DiMaggio]

Buyback is on

[oleskool]

can this hit 2$ , gut says not gonna happen

[tw0122]

See $4 zone ($4.20$4.54) as resistance now with the news eliminating debt and liabilities. Moves up slowly..
Tevogen reiterated its confidence in its financial stability, confirming sufficient available capital to fund operations for at least the next 33 months, supported by a loan agreement, which Tevogen entered into in June. Additionally, Tevogen eliminated almost all of its liabilities which were $99.9 million as reported at December 31, 2023 and now are $10.5 million as reported at September 30, 2024.





Tevogen’s internally developed intellectual property and product assets, valued internally at $10 billion+ using discounted cash flow models, are not reflected on the balance sheet. Due to US GAAP accounting rules, the company was unable to report the fair market value of its assets, including proprietary immunotherapy technologies and cutting-edge artificial intelligence platforms. The company believes that the inclusion of Tevogen’s IP assets on its balance sheet would significantly enhance its enterprise value



Commenting on the company’s performance and unique ownership structure, Dr. Saadi concluded, “Tevogen’s leadership stands apart in the biotech sector, with approximately 78% of equity retained by our officers, an extraordinary figure compared to the industry average of just 4%. In addition to our officers, our key employees have also been granted substantial restricted stock units in the company, reflecting our belief that our employees should also be owners of our success.”

[glenn1919]

TVGN.........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[glenn1919]

TVGN..........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[BurgerKing82]

Looks interesting

[glenn1919]

TVGN..................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

[tw0122]

$1.32 + 10% .. WARREN, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, nears finalization of agreement with CD8 Technology for a turn-key facility intended to support both pre-clinical research and GMP manufacturing capabilities, staffed by Tevogen.

[OffTheGrid]

Adding 

[HoldEm777]

https://www.stocktitan.net/news/TVGNW/tevogen-bio-expands-on-microsoft-partnership-to-integrate-machine-zepglnzxz4n7.html

[BardRaider17]

Yes sir

[getitrit]

Is it true they are partners with Microsoft?

[BardRaider17]

I think I messed up. I'm sitting on 555 @ average 2.58 I really did not want to be stuck in that overnight. Thoughts?

[tw0122]

Flip out some $2.60s 

[tw0122]

Back in $2.20s for a flip maybe quick hopefully longer 

[tw0122]

Not much pumped some premarket so always careful have to see if $2.29- $2.47 zone holds afee profit taking then will add some perhaps 

[BardRaider17]

Can you explain what that means for me? Im new TY

[tw0122]

TVGN 3.20 trading float about 21m about 15m traded so far 

[tw0122]

TVGN $4s coming will trade whole float by 930am

[tw0122]

Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week

October 22 2024 - 2:30PM

Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to provide further updates on the previously announced revenue forecast for Tevogen Oncology and Tevogen Specialty Care therapeutic areas by the end of this week. The revenue forecast for the two therapeutic areas is approximately $1 billion each in their respective launch years. The 5-year combined estimate for the two therapeutic areas is between $28 billion and $36 billion.

Tevogen Bio also plans to update shareholders on Tevogen AI, its proprietary artificial intelligence effort, designed to advance a mission to lower the total cost of drug development, expedite drug discovery, and deliver life-changing therapies to large patient populations. In addition, Tevogen Bio will provide an update on clinical and commercial manufacturing.

[tw0122]

TVGN 3.75 -3.88 zone up there and then $4.27 on high side in the 2.62-3.40 zone for now

[glenn1919]

tvgn............................https://stockcharts.com/h-sc/ui?s=tvgn&p=W&b=5&g=0&id=p86431144783

[dinogreeves]

Actually buying more tomorrow, price targets changed 16-18 dollars by year end.

[eur06]

In less than 2 years CVNA went absolutely nuts wow!!!
TVGN

[da_stock_analyst]

#TVGN 🔥 70% short interest & $TVGN squeezing! watch this week!

[frans]

thanks

[dinogreeves]

SAVE could do similar pattern as CVNA did.

[dinogreeves]

For me personally not going to wait 10-12. I will sell at $6.00

[frans]

SAVE - when to 10 - 12 $ and who is selling all those shares?

[dinogreeves]

SAVE will run big 10-12 dollars

[eur06]

Wow uavs!!!!
save still ok ?
TVGN

[dinogreeves]

It was a great setup, I was looking for the Microsoft deal to come through and it did. Made my move on SAVE and UAVS.

[dinogreeves]

No loaded 4000 shares this morning, it should run to 7-8 dollars but it will get to 10-12 dollar range. Float is next to nothing. They have contracts with the French Army and the United Nations. Severly undervalued.

[eur06]

Wow that chart looks hot hot hot..lol
Just got some…waiting for updates?
TVGN

[tw0122]

TVGN 2.90 time to flip this champ again. Happy trading